Effects of metformin extended release compared to immediate release formula on glycemic control and glycemic variability in patients with type 2 diabetes
Giuseppe Derosa,1–4 Angela D’Angelo,1,4 Davide Romano,1 Pamela Maffioli1,5 1Department of Internal Medicine and Therapeutics, Centre of Diabetes and Metabolic Diseases, 2Centre for the Study of Endocrine-Metabolic Pathophysiology and Clinical Research, 3Centre for Prevention, Sur...
Saved in:
Main Authors: | Derosa G (Author), D'Angelo A (Author), Romano D (Author), Maffioli P (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2017-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ertugliflozin: a sodium-glucose cotransporter-2 (SGLT-2) inhibitor for glycemic control in type 2 diabetes
by: Derosa G, et al.
Published: (2018) -
Impact of Gliclazide Modified Release or Glimepiride as Add-on Therapy to Metformin on Glycemic and Oxidative Stress Parameters in Type 2 Diabetic Patients
by: Fadhel A. Shehab, et al.
Published: (2024) -
Treatment-Continuity of ADHD Compared Using Immediate-Release and Extended-Release MPH
by: J Gordon Millichap
Published: (2005) -
Evaluation of Metformin + Sitagliptin versus Metformin + Glibenclamide on Glycemic Control in Iraqis Type 2 Diabetic Patients
by: Hassan M. Al-Temimi, et al.
Published: (2017) -
Evaluation of Metformin + Sitagliptin versus Metformin + Glibenclamide on Glycemic Control in Iraqis Type 2 Diabetic Patients
by: Hassan M. Al-Temimi, et al.
Published: (2017)